Lv1
86 积分 2024-05-25 加入
AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals
1小时前
已完结
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
13小时前
已完结
Global burden of hepatitis B virus: current status, missed opportunities and a call for action
7天前
已完结
Efficacy and safety of immune checkpoint inhibitors in lung cancer patients with hepatitis B surface antigen positivity: a real-world cohort study
1个月前
已完结
Immune Checkpoint Inhibitor-Induced Rapid Decline in Hepatitis B Virus Markers Improves the Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients
1个月前
已完结
Anti-PD-1 monoclonal antibody suppresses hepatitis B virus in patients with hepatocellular carcinoma
1个月前
已完结
Significance of anti-HBc alone serological status in clinical practice
5个月前
已完结
Twenty-four-week anti-PD-1 antibody regimen promoted HBsAg reduction and concurrently enhanced HBV-specific T cell responses in patients with chronic hepatitis B
5个月前
已完结
Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors
10个月前
已完结
PD-1 blockade partially recovers dysfunctional virus–specific B cells in chronic hepatitis B infection
10个月前
已完结
皖公网安备34019202002308
